[The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure Evaluation Trial].
Shimamoto
Ken
K
Ken Shimamoto, Department of Cardiology, Aoyama Hospital Tokyo Women's Medical University.
Kawana
Masatoshi
M
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D002227:Carbazoles / Q000008:administration & dosage*; D000077261:Carvedilol; D002986:Clinical Trials as Topic; D004656:Enalapril / Q000008:administration & dosage / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D011412:Propanolamines / Q000008:administration & dosage*; D012107:Research Design; D020257:Ventricular Remodeling / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002227:Carbazoles; D011412:Propanolamines; D000077261:Carvedilol; D004656:Enalapril